More than six years following the onset of the Covid pandemic, millions of individuals continue to experience long Covid symptoms. Researchers at University College London and University College London Hospitals have published findings from a clinical trial examining potential treatments for the condition.
The trial evaluated over-the-counter antihistamines alongside colchicine, a prescription anti-inflammatory medication. Results indicated these treatments produced a small reduction in fatigue levels among participants with long Covid. However, researchers have clarified that the findings do not represent a curative treatment for the condition. Professor Danny Altmann, an immunologist at Imperial College London, has provided commentary on the research and discussed ongoing challenges in understanding the underlying mechanisms of long Covid. He also highlighted several studies currently underway that may contribute to improved comprehension of the condition.
In related health news, statistics indicate that approximately one in 335 people in the United Kingdom are living with a stoma. According to Colostomy UK, more than 60 per cent of individuals with a stoma report that insufficient toilet facilities impact their quality of life. A campaign originating in Bristol has resulted in B&Q retrofitting disabled toilet facilities across its store locations to accommodate the needs of stoma patients. The initiative has been documented with participation from both individuals with lived experience of stoma management and medical professionals specializing in colorectal care.
Separately, circulating social media claims have suggested that ice cream consumption may reduce the risk of developing type 2 diabetes. Nutritional scientists have been consulted to evaluate these assertions, examining what has been termed the ‘ice cream paradox’ in relation to actual scientific evidence concerning frozen desserts and metabolic health outcomes.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI